Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Varicella Virus Vaccine Live · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Open label |
| Name | Type | Description |
|---|---|---|
| Varicella Virus Vaccine Live (Oka-Merck) | BIOLOGICAL | VARIVAX(TM) (Refrigerated) \[Varicella Virus Vaccine Live (Oka/Merck), Refrigerator-Stable Formulation.\] Subjects enrolled in the study received one 0.5 mL subcutaneous dose of VARIVAX(TM). Frequency is single dose. |
Inclusion Criteria: * Healthy Children, Between 12 Months And 12 Years Of Age * Parent Or Legal Guardian Should Be Willing And Able To Sign The Informed Consent Form Prior To Entry Into The Study Exclusion Criteria: * Any Immune Impairment Or Deficiency, Neoplastic Disease, Or Depressed Immunity,...
Varicella Virus Vaccine Live is used for varicella, the disease commonly known as chickenpox. It is a live vaccine designed to protect against this infectious disease. The vaccine is being studied in healthy children aged 12 years and older.
Varicella Virus Vaccine Live is developed by Merck & Company, Inc., a pharmaceutical company traded on the New York Stock Exchange under the ticker symbol MRK. Merck is conducting clinical trials to evaluate the vaccine's safety and immunogenicity.
Varicella Virus Vaccine Live is in Phase 3 clinical development. It is an investigational vaccine and has not been approved by regulatory authorities. The Phase 3 trial has been completed, and the vaccine remains under clinical investigation.
Varicella Virus Vaccine Live has one completed Phase 3 clinical trial registered as NCT00496327. The trial, titled 'Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)', enrolled 100 healthy children aged 12 years and older to evaluate the vaccine.
Yes, Varicella Virus Vaccine Live is the same as VARIVAX. The clinical trial NCT00496327 refers to the vaccine as VARIVAX, indicating that VARIVAX is the brand name for this live varicella vaccine developed by Merck.